Dignitana AB (publ) (DIGN.ST)
SEK 0.92
(-2.65%)
SEK 0.92
(-2.65%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -17.36 Million SEK | 22.52% |
| 2022 | -22.41 Million SEK | 47.99% |
| 2021 | -43.08 Million SEK | 21.56% |
| 2020 | -54.92 Million SEK | -44.41% |
| 2019 | -38.03 Million SEK | -46.17% |
| 2018 | -26.02 Million SEK | 38.92% |
| 2017 | -42.6 Million SEK | -32.02% |
| 2016 | -32.26 Million SEK | -94.76% |
| 2015 | -16.56 Million SEK | -51.81% |
| 2014 | -10.91 Million SEK | 34.09% |
| 2013 | -16.56 Million SEK | -25.17% |
| 2012 | -13.23 Million SEK | -261.08% |
| 2011 | -3.66 Million SEK | 83.0% |
| 2010 | -21.55 Million SEK | -100.07% |
| 2009 | -10.77 Million SEK | 21.5% |
| 2008 | -13.72 Million SEK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -11.45 Million SEK | -126.54% |
| 2024 Q1 | -5.05 Million SEK | 0.43% |
| 2023 Q3 | -3.68 Million SEK | 20.96% |
| 2023 FY | -17.36 Million SEK | 22.52% |
| 2023 Q4 | -5.07 Million SEK | -37.8% |
| 2023 Q1 | -4.38 Million SEK | 63.46% |
| 2023 Q2 | -4.66 Million SEK | -6.22% |
| 2022 Q3 | -4.04 Million SEK | -455.98% |
| 2022 Q4 | -12.01 Million SEK | -197.15% |
| 2022 FY | -22.41 Million SEK | 47.99% |
| 2022 Q1 | -6.87 Million SEK | 41.96% |
| 2022 Q2 | -727 Thousand SEK | 89.43% |
| 2021 Q1 | -7.66 Million SEK | 63.19% |
| 2021 Q3 | -14.23 Million SEK | -47.4% |
| 2021 Q4 | -11.84 Million SEK | 16.81% |
| 2021 FY | -43.08 Million SEK | 21.56% |
| 2021 Q2 | -9.66 Million SEK | -26.04% |
| 2020 FY | -54.92 Million SEK | -44.41% |
| 2020 Q1 | -12.75 Million SEK | 15.32% |
| 2020 Q3 | -9.85 Million SEK | -3.47% |
| 2020 Q4 | -20.82 Million SEK | -111.19% |
| 2020 Q2 | -9.52 Million SEK | 25.3% |
| 2019 Q2 | -7.48 Million SEK | -40.59% |
| 2019 Q1 | -5.32 Million SEK | 0.92% |
| 2019 Q3 | -10.17 Million SEK | -35.96% |
| 2019 Q4 | -15.06 Million SEK | -48.11% |
| 2019 FY | -38.03 Million SEK | -46.17% |
| 2018 Q3 | -6.34 Million SEK | -18.14% |
| 2018 Q1 | -8.95 Million SEK | 32.89% |
| 2018 Q2 | -5.37 Million SEK | 39.97% |
| 2018 Q4 | -5.37 Million SEK | 15.41% |
| 2018 FY | -26.02 Million SEK | 38.92% |
| 2017 FY | -42.6 Million SEK | -32.02% |
| 2017 Q4 | -13.33 Million SEK | -29.03% |
| 2017 Q3 | -10.33 Million SEK | 4.39% |
| 2017 Q2 | -10.81 Million SEK | -33.34% |
| 2017 Q1 | -8.1 Million SEK | 30.24% |
| 2016 Q4 | -11.62 Million SEK | -64.43% |
| 2016 Q3 | -7.06 Million SEK | 7.85% |
| 2016 FY | -32.26 Million SEK | -94.76% |
| 2016 Q1 | -5.9 Million SEK | -12.16% |
| 2016 Q2 | -7.67 Million SEK | -29.96% |
| 2015 Q4 | -5.26 Million SEK | -25.81% |
| 2015 FY | -16.56 Million SEK | -51.81% |
| 2015 Q3 | -4.18 Million SEK | 4.56% |
| 2015 Q2 | -4.38 Million SEK | -59.98% |
| 2015 Q1 | -2.73 Million SEK | -151.38% |
| 2014 Q2 | -2.46 Million SEK | 49.61% |
| 2014 Q1 | -4.89 Million SEK | -3.72% |
| 2014 FY | -10.91 Million SEK | 34.09% |
| 2014 Q4 | -1.08 Million SEK | 55.61% |
| 2014 Q3 | -2.45 Million SEK | 0.54% |
| 2013 Q2 | -4.48 Million SEK | -17.04% |
| 2013 Q1 | -3.83 Million SEK | 31.6% |
| 2013 Q3 | -3.51 Million SEK | 21.56% |
| 2013 Q4 | -4.72 Million SEK | -34.27% |
| 2013 FY | -16.56 Million SEK | -25.17% |
| 2012 FY | -13.23 Million SEK | -261.08% |
| 2012 Q1 | -1.53 Million SEK | 79.4% |
| 2012 Q3 | -3.11 Million SEK | -4.65% |
| 2012 Q4 | -5.6 Million SEK | -79.94% |
| 2012 Q2 | -2.97 Million SEK | -93.27% |
| 2011 Q1 | -3.2 Million SEK | 75.31% |
| 2011 Q2 | 6.13 Million SEK | 291.41% |
| 2011 FY | -3.66 Million SEK | 83.0% |
| 2011 Q4 | -7.47 Million SEK | -139.21% |
| 2011 Q3 | -3.12 Million SEK | -150.88% |
| 2010 Q1 | -2.77 Million SEK | 40.27% |
| 2010 Q2 | -3.64 Million SEK | -31.36% |
| 2010 Q4 | -12.99 Million SEK | -504.83% |
| 2010 Q3 | -2.14 Million SEK | 41.04% |
| 2010 FY | -21.55 Million SEK | -100.07% |
| 2009 Q4 | -4.64 Million SEK | -308.9% |
| 2009 Q2 | -3.04 Million SEK | -55.64% |
| 2009 FY | -10.77 Million SEK | 21.5% |
| 2009 Q1 | -1.95 Million SEK | 0.0% |
| 2009 Q3 | -1.13 Million SEK | 62.67% |
| 2008 FY | -13.72 Million SEK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acarix AB (publ) | -77.83 Million SEK | 77.694% |
| ADDvise Group AB (publ) | 103.5 Million SEK | 116.776% |
| ADDvise Group AB (publ) | 103.5 Million SEK | 116.776% |
| Arcoma AB | 2.56 Million SEK | 777.184% |
| Bactiguard Holding AB (publ) | -138.38 Million SEK | 87.453% |
| BICO Group AB (publ) | -835.7 Million SEK | 97.922% |
| Boule Diagnostics AB (publ) | 24.97 Million SEK | 169.516% |
| CellaVision AB (publ) | 130.3 Million SEK | 113.324% |
| Clinical Laserthermia Systems AB (publ) | -79.79 Million SEK | 78.24% |
| Chordate Medical Holding AB (publ) | -29.18 Million SEK | 40.511% |
| C-Rad AB (publ) | 35.52 Million SEK | 148.87% |
| Duearity AB (publ) | -26.19 Million SEK | 33.704% |
| Episurf Medical AB (publ) | -94.8 Million SEK | 81.685% |
| Getinge AB (publ) | 2.41 Billion SEK | 100.72% |
| Scandinavian Real Heart AB (Publ) | -67.97 Million SEK | 74.458% |
| Iconovo AB (publ) | -45.89 Million SEK | 62.167% |
| Integrum AB (publ) | 4.03 Million SEK | 530.579% |
| Luxbright AB (publ) | -25.37 Million SEK | 31.575% |
| Mentice AB (publ) | -2.81 Million SEK | -516.365% |
| OssDsign AB (publ) | -130.49 Million SEK | 86.694% |
| Paxman AB (publ) | 8.33 Million SEK | 308.439% |
| Promimic AB (publ) | -9.22 Million SEK | -88.278% |
| Qlife Holding AB (publ) | -159.95 Million SEK | 89.145% |
| SciBase Holding AB (publ) | -55.58 Million SEK | 68.763% |
| ScandiDos AB (publ) | -14.64 Million SEK | -18.543% |
| Sectra AB (publ) | 428.38 Million SEK | 104.053% |
| Sedana Medical AB (publ) | -59.61 Million SEK | 70.873% |
| Senzime AB (publ) | -134.14 Million SEK | 87.057% |
| SpectraCure AB (publ) | -20.44 Million SEK | 15.058% |
| Stille AB | 26.64 Million SEK | 165.162% |
| Vitrolife AB (publ) | -3.85 Billion SEK | 99.549% |
| Xvivo Perfusion AB (publ) | 91.82 Million SEK | 118.91% |